Sharad Kole Amit, Narayan Dorkar Shashikant, Bhagwatkumar Panchal Shivani
Department of ENT, Bharati Vidyapeeth (Deemed To Be University) Medical College and Hospital, OPD No. 9, Sangli, Maharashtra India.
Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):3053-3056. doi: 10.1007/s12070-023-03784-4. Epub 2023 Jun 7.
A prospective comparative study was carried out in patients attending ENT Out Patient Department of a tertiary care Hospital with an aim to determine the association of adenoid hypertrophy with chronic nasal and middle ear pathologies in those aged 18 years or above. Patients presenting between August 2020 and February 2022 with chronic nasal and middle ear pathologies who underwent diagnostic nasal endoscopy were seen for adenoid hypertrophy and its association was analysed statistically. Adenoid hypertrophy (AH) in 18-25, 26-35, 36-45 and 46-55 years age group are 56.25, 28.12, 12.5, 3.125% respectively with a male:female ratio of 3:1. None of the patients were above 56 years in the study. No statistically significant association could be derived between chronic nasal and middle ear pathologies with AH. AH is a vital cause of nasal obstruction in adult population with a rising frequency these days owing to allergy, chronic infection and increased pollution. The entire of the individuals presenting with nasal obstruction, snoring and other nasal symptoms and chronic middle ear pathologies; AH should at all times be kept in mind as a ground and the patients shall be appraised for adenoid hypertrophy.
在一家三级医院的耳鼻喉科门诊对患者进行了一项前瞻性对照研究，目的是确定18岁及以上患者腺样体肥大与慢性鼻和中耳病变之间的关联。对2020年8月至2022年2月期间因慢性鼻和中耳病变接受诊断性鼻内镜检查的患者进行观察，分析腺样体肥大情况及其关联。18 - 25岁、26 - 35岁、36 - 45岁和46 - 55岁年龄组的腺样体肥大（AH）发生率分别为56.25%、28.12%、12.5%、3.125%，男女比例为3:1。研究中没有患者年龄超过56岁。慢性鼻和中耳病变与腺样体肥大之间未发现统计学上的显著关联。腺样体肥大是成人鼻阻塞的一个重要原因，近年来由于过敏、慢性感染和污染增加，其发生率呈上升趋势。对于所有出现鼻阻塞、打鼾和其他鼻部症状以及慢性中耳病变的个体，应始终将腺样体肥大作为一个考虑因素，并对患者进行腺样体肥大评估。
